MedTrace Logo

Effect of Lidocaine in Reducing Opioids Requirement in Day Care Surgery

NCT06717672 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-12-10

No results posted yet for this study

Summary

1. \*Reduced opioid consumption
2. \*Decreased pain scores
3. \*Fewer opioid-related side effects
4. \*Improved patient satisfaction

Conditions

  • Pain
  • Post-operative Pain Control
  • Post-operative Pain

Interventions

DRUG

Lidocaine 2% without vessel constrictor

1. \_Lidocaine 2% provides rapid and effective local anesthesia for minor surgical procedures, such as biopsies, excisions, and suturing. 2. \_Pain relief\_: Lidocaine 2% has been shown to provide significant pain relief in patients with acute pain, such as post-operative pain, trauma, and burns. 3. \_Reducing pain intensity\_: Lidocaine 2% has been shown to reduce pain intensity by 30-50% in various clinical studies.

DRUG

Normal Saline

Normal saline used is an iv fluid given for fluid replacement

Sponsors & Collaborators

  • Liaquat National Hospital & Medical College

    lead OTHER

Principal Investigators

  • Hanesh Tanwani Dr Hanesh Tanwani · Liaquat National Hospital and Medical College

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-05
Primary Completion
2024-05-10
Completion
2024-05-10

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06717672 on ClinicalTrials.gov